Syphilis remains a significant public health challenge, with reported cases in the United States rising dramatically over the last two decades. The infection progresses through primary, secondary, latent, and tertiary stages, each requiring distinct diagnostic and treatment approaches. Benzathine penicillin G serves as the primary therapeutic intervention, though specific protocols vary for patients with HIV or during pregnancy. Beyond clinical management, the history of the Tuskegee Syphilis Study—a 40-year unethical experiment on African American men—highlights the systemic roots of medical distrust and the necessity of rigorous ethical standards in research. Effective control relies on consistent screening, partner notification, and adherence to CDC guidelines, particularly for high-risk populations. Addressing these historical and systemic disparities is essential to mitigating the impact of this bacterial infection and ensuring equitable healthcare delivery.
Sign in to continue reading, translating and more.
Continue
